NNNN

Peers: ICUI AVTR TFX BAX BDX RMD GKOS EW BSX MDT

Index	-
Market Cap	801.47M
Enterprise Value	787.49M
Income	7.19M
Sales	9.74M
Book/sh	0.81
Cash/sh	0.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	27
IPO	Feb 19, 2025

P/E	34.03
Forward P/E	-
PEG	-
P/S	82.29
P/B	6.90
P/C	57.33
P/FCF	-
EV/EBITDA	121.53
EV/Sales	80.85
Quick Ratio	344.31
Current Ratio	344.31
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.16
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-12.86% 23.44%
Sales past 3/5Y	-26.67% 16.85%
EPS Y/Y TTM	170.13%
Sales Y/Y TTM	10.10%
EPS Q/Q	321.09%
Sales Q/Q	87.39%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	9.57%
Insider Trans	0.00%
Inst Own	0.16%
Inst Trans	1.39%
ROA	26.08%
ROE	27.01%
ROIC	20.29%
Gross Margin	87.06%
Oper. Margin	66.47%
Profit Margin	73.75%
SMA20	-17.11%
SMA50	-34.44%
SMA200	-74.23%
Trades

Shs Outstand	43.89M
Shs Float	39.69M
Short Float	0.15%
Short Ratio	0.44
Short Interest	0.06M
52W High	51.33 -89.15%
52W Low	5.25 6.10%
Volatility	8.81% 10.10%
ATR (14)	0.84
RSI (14)	24.85
Beta	5.34
Rel Volume	1.97
Avg Volume	132.27K
Volume	241,721

Perf Week	-12.15%
Perf Month	-28.13%
Perf Quarter	-66.53%
Perf Half Y	-74.11%
Perf YTD	-81.48%
Perf Year	-86.86%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	5.60
Price	5.57
Change %	-0.54%

Mar-17-26 04:30PM	Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Jan-26-26 01:12PM	Stock Market Today: Trump's Medicare announcement slams health insurers (TheStreet) -24.73%
Aug-08-25 09:05PM	Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System (GlobeNewswire) +10.88% -7.89%
Jul-09-25 10:31AM	Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN) (Insider Monkey) +14.50%
Jul-04-25 06:00AM	The IPO market in 2025 is being driven by a clear theme bigger is better (Yahoo Finance)
01:05AM	Loading…
May-15-25 01:05AM	Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions (GlobeNewswire) +6.12%
Feb-20-25 09:50AM	Anbio Biotechnology Announces Closing of Initial Public Offering (GlobeNewswire)
Feb-18-25 06:10PM	Anbio Biotechnology Announces Pricing of Initial Public Offering (GlobeNewswire)

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.

Ph.D.Mr. Michael Lau M.B.A.

Chief Financial OfficerMs. Suki Song CPA

Chief Business OfficerMr. Chris Tian

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Anbio Biotechnology

Upgrade your Finviz experience